Search Results - "Mungo, Eleonora"
-
1
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
Published in International journal of molecular sciences (21-05-2019)“…The extracellular signal-related kinases (ERKs) act as pleiotropic molecules in tumors, where they activate pro-survival pathways leading to cell proliferation…”
Get full text
Journal Article -
2
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
Published in Molecular cancer therapeutics (01-11-2016)“…Doxorubicin is one of the leading drugs for osteosarcoma standard chemotherapy. A total of 40% to 45% of high-grade osteosarcoma patients are unresponsive, or…”
Get full text
Journal Article -
3
Knock-Out of IKKepsilon Ameliorates Atherosclerosis and Fatty Liver Disease by Alterations of Lipid Metabolism in the PCSK9 Model in Mice
Published in International journal of molecular sciences (01-10-2024)“…The inhibitor-kappaB kinase epsilon (IKKε) represents a non-canonical IκB kinase that modulates NF-κB activity and interferon I responses. Inhibition of this…”
Get full text
Journal Article -
4
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells
Published in International journal of molecular sciences (10-11-2018)“…Emerging evidence supports the idea that a dysfunction in cell metabolism could sustain a resistant phenotype in cancer cells. As the success of…”
Get full text
Journal Article -
5
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells
Published in Frontiers in pharmacology (13-08-2018)“…Diabetes and cancer are common, chronic, and potentially fatal diseases that frequently co-exist. Observational studies clearly indicate that the risk of…”
Get full text
Journal Article -
6
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
Published in Journal of experimental & clinical cancer research (27-11-2018)“…Triple negative breast cancer (TNBC) easily develops resistance to the first-line drug doxorubicin, because of the high levels of the drug efflux transporter…”
Get full text
Journal Article -
7
Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
Published in Journal of antimicrobial chemotherapy (01-11-2019)“…Abstract Objectives The β-lactam/β-lactamase inhibitor combination ceftazidime/avibactam is active against KPC-producing Enterobacterales. Herein, we present…”
Get full text
Journal Article -
8
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?
Published in Seminars in cell & developmental biology (01-02-2020)“…•Metabolites released from mitochondria help cancer cells to evade immune system.•Effector and immune-suppressive cells have a different mitochondria…”
Get full text
Journal Article -
9
Distinct molecular mechanisms contribute to the reduction of melanoma growth and tumor pain after systemic and local depletion of alpha‐Synuclein in mice
Published in The FASEB journal (01-12-2023)“…Epidemiological studies show a coincidence between Parkinson's disease (PD) and malignant melanoma. It has been suggested that this relationship is due, at…”
Get full text
Journal Article -
10
Increasing intratumor C/EBP-[beta] LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
Published in Journal of experimental & clinical cancer research (27-11-2018)“…Background Triple negative breast cancer (TNBC) easily develops resistance to the first-line drug doxorubicin, because of the high levels of the drug efflux…”
Get full text
Journal Article -
11
Klebsiella pneumoniae : Emergence of multi-drug-resistant strains in Northwest Italy
Published in The Journal of infection (01-05-2012)Get full text
Journal Article